12-11-2024 |
PM |
|
NVAX |
Novavax, Inc. |
1,430 |
-0.76 |
-0.87 |
-1.26 |
Novavax beats top-line and bottom-line estimates; updates FY24 outlook [11/12/2024 8:04 AM] |
8.44 |
-0.57 (-6.38%) |
7.96 |
-1.05 (-11.65%) |
3.53 - 23.86 |
7,959,888 |
5,230,000 |
1,899,116 |
|
|
08-08-2024 |
PM |
|
NVAX |
Novavax, Inc. |
1,620 |
0.99 |
1.35 |
0.58 |
Novavax GAAP EPS of $0.99 misses by $0.68, revenue of $415.48M misses by $13M [8/8/2024 7:49 AM] |
11.66 |
0.95 (8.92%) |
8.98 |
-1.73 (-16.15%) |
3.53 - 23.86 |
10,356,992 |
8,380,000 |
1,371,663 |
|
|
10-05-2024 |
PM |
|
NVAX |
Novavax, Inc. |
625.59 |
-1.05 |
-1.04 |
-3.41 |
Novavax reports mixed Q1 results; narrows FY24 revenue outlook below estimates [5/10/2024 3:38 AM] |
8.89 |
4.42 (98.99%) |
10.07 |
5.60 (125.28%) |
3.53 - 11.00 |
127,661,248 |
4,280,000 |
37,907,560 |
|
|
28-02-2024 |
PM |
|
NVAX |
Novavax |
628.00 |
-1.44 |
-0.49 |
0.00 |
Novavax GAAP EPS of -$1.44 misses by $0.99, revenue of $291M misses by $30.97M [2/28/2024 8:01 AM] |
4.40 |
-1.62 (-26.91%) |
4.66 |
-1.36 (-22.59%) |
3.53 - 11.36 |
26,578,159 |
12,600,000 |
3,141,754 |
|
|
09-11-2023 |
PM |
|
NVAX |
Novavax, Inc. |
669.33 |
-1.26 |
-1.82 |
-2.15 |
Novavax beats Q3 top and bottom line estimates; initiates Q1 and updates FY23 outlook [11/9/2023 8:04 AM] |
6.72 |
-0.08 (-1.18%) |
6.97 |
0.17 (2.50%) |
5.61 - 25.66 |
8,825,417 |
5,290,000 |
398,241 |
|
|
08-08-2023 |
PM |
|
NVAX |
Novavax, Inc. |
695.62 |
0.58 |
-1.24 |
-6.53 |
Novavax GAAP EPS of $0.58 beats by $1.74, revenue of $424.43M beats by $165.44M [8/8/2023 6:40 AM] |
7.25 |
-0.27 (-3.59%) |
8.17 |
0.65 (8.64%) |
5.61 - 62.75 |
25,212,010 |
5,220,000 |
3,675,613 |
|
|
09-05-2023 |
PM |
Before the open (May 9) |
NVAX |
Novavax, Inc. |
664.40 |
-3.41 |
-3.38 |
2.56 |
Novavax reports mixed Q1 earnings; updates FY23 outlook [5/9/2023 6:36 AM] |
9.54 |
2.09 (28.12%) |
9.03 |
1.58 (21.19%) |
5.61 - 76.77 |
39,799,436 |
3,820,000 |
1,610,857 |
|
|
28-02-2023 |
AH |
4:00 PM ET (Feb 28) |
NVAX |
Novavax, Inc. |
773.54 |
-2.28 |
-0.92 |
-11.18 |
Novavax GAAP EPS of -$2.28 misses by $1.27, revenue of $357.4M misses by $25.74M [2/28/2023 4:06 PM] |
6.83 |
-2.43 (-26.30%) |
6.97 |
-2.29 (-24.73%) |
6.64 - 91.00 |
18,728,644 |
5,230,000 |
3,066,898 |
|
|
08-11-2022 |
AH |
4:00 PM ET (Nov 8) |
NVAX |
Novavax, Inc. |
1,580 |
-2.15 |
2.21 |
-4.31 |
Novavax GAAP EPS of -$2.15 misses by $3.79, revenue beats estimates, lowers revenue guidance [11/8/2022 4:03 PM] |
18.62 |
-1.03 (-5.24%) |
19.65 |
0.0 (0.00%) |
16.00 - 236.50 |
5,771,033 |
4,210,000 |
66,437 |
|
-
Novavax GAAP EPS of -$2.15 misses by $3.79, revenue beats estimates, lowers revenue guidance [11/8/2022 4:03 PM]
-
Novavax says Phase 3 data support booster effect of COVID-19 shot against Omicron [11/8/2022 8:50 AM]
-
Novavax updated 2022 revenue guidance falls below consensus estimate [11/8/2022 4:27 PM]
-
Novavax COVID-19 shot authorized as booster in UK [11/9/2022 9:55 AM]
-
The Make-Or-Break Moment For Novavax: What To Watch In Third-Quarter Earnings [Nov-08-22 01:42PM]
-
China sees violent protests against COVID restrictions, and U.S. cases have been rising [Nov-08-22 01:11PM]
-
Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses [Nov-08-22 12:33PM]
-
Novavax says its Omicron-specific vaccine candidate works as a booster [Nov-08-22 11:55AM]
-
Novavax says Phase 3 trial of omicron-targeting COVID vaccine supports its use as a booster [Nov-08-22 08:11AM]
-
Novavax says Omicron shot shows strong immune response as second booster [Nov-08-22 08:04AM]
-
Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster [Nov-08-22 08:00AM]
-
Novavax quadruples revenue in Q3, but lowers guidance for the year [Nov-08-22 07:55PM]
-
Top trending stocks after hours: Disney, AMC, Affirm, and more [Nov-08-22 06:08PM]
-
Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates [Nov-08-22 05:45PM]
-
Stocks moving in after hours: Disney, AMC, Affirm, Novavax, Marathon Digital [Nov-08-22 04:58PM]
-
UPDATE 2-Novavax cuts full-year revenue forecast again amid weak demand [Nov-08-22 04:31PM]
-
UPDATE 1-Novavax cuts full-year revenue forecast [Nov-08-22 04:31PM]
-
Novavax stock rallies, even as company offers a dimmer sales forecast for vaccines [Nov-08-22 04:29PM]
-
Novavax cuts full-year revenue forecast again amid weak demand [Nov-08-22 04:21PM]
-
Novavax More Than Quadruples Third-Quarter Sales, But Outlook Dims [Nov-08-22 04:19PM]
-
Novavax cuts full-year revenue forecast [Nov-08-22 04:02PM]
-
Novavax Reports Third Quarter 2022 Financial Results and Operational Highlights [Nov-08-22 04:02PM]
|
08-08-2022 |
AH |
4:00 PM ET (Aug 8) |
NVAX |
Novavax, Inc. |
4,290 |
-6.53 |
5.51 |
-4.75 |
Novavax GAAP EPS of -$6.53, revenue of $185.93M misses by $834.07M, lowers 2022 revenue forecast [8/8/2022 4:03 PM] |
40.25 |
-17.00 (-29.69%) |
40.00 |
-17.25 (-30.13%) |
34.88 - 277.80 |
24,836,748 |
4,600,000 |
1,781,572 |
|
|
09-05-2022 |
AH |
4:00 PM ET (May 9) |
NVAX |
Novavax, Inc. |
4,580 |
2.56 |
3.33 |
-3.05 |
Novavax GAAP EPS of $2.56 misses by $0.09, revenue of $703.97M misses by $141.23M [5/9/2022 4:04 PM] |
54.15 |
0.89 (1.67%) |
42.19 |
-11.07 (-20.78%) |
42.13 - 277.80 |
12,071,310 |
4,309,461 |
659,547 |
|
-
Novavax GAAP EPS of $2.56 misses by $0.09, revenue of $703.97M misses by $141.23M [5/9/2022 4:04 PM]
-
Novavax down 10% after hours on Q1 top and bottom line misses [5/9/2022 4:39 PM]
-
Novavax quarterly results further weigh on vaccine developer down 67% YTD [5/10/2022 10:46 AM]
-
Novavax Guides To At Least $4 Billion In 2022 Sales Is It A Buy Now? [May-06-22 10:00AM]
-
Is a Surprise Coming for Novavax (NVAX) This Earnings Season? [May-06-22 08:52AM]
-
Why Novavax Is Crushing It This Week [May-06-22 05:50AM]
-
Could Novavax Stock Help You Retire a Millionaire? [May-09-22 07:05AM]
-
Novavax posts first quarterly profit, but misses expectations [May-09-22 04:29PM]
-
UPDATE 1-Novavax 2022 COVID vaccine deliveries off to slow start [May-09-22 04:28PM]
-
Novavax Crashes As Alternative To Pfizer, Moderna Covid Shots Lags Estimates [May-09-22 04:20PM]
-
Novavax reports 'first profitable quarter' amid global Covid-19 vaccine momentum [May-09-22 04:08PM]
-
Novavax Reports First Quarter 2022 Financial Results and Operational Highlights [May-09-22 04:02PM]
-
Novavax reports 'first profitable quarter' amid Covid-19 vaccine work, but misses revenue forecasts [May-09-22 04:08PM]
-
Novavax (NVAX) Q1 Earnings and Revenues Lag Estimates [May-09-22 05:35PM]
-
UPDATE 2-Novavax 2022 COVID vaccine deliveries off to slow start, shares drop [May-09-22 04:28PM]
-
Novavax Stock Tanks as Profit and Sales Badly Trail Estimates [May-10-22 04:23AM]
-
Stock Market Plunge: 5 Discounted Growth Stocks to Buy Now and Hold Forever [May-10-22 05:06AM]
-
Novavax Missed Q1 Estimates By a Mile: Should Investors Worry? [May-10-22 05:51AM]
-
Novavax shares slide 20% on COVID vaccine demand uncertainty [May-10-22 08:29AM]
-
Novavax posts first profitable quarter amid global COVID-19 vaccine rollout [May-10-22 09:47AM]
-
Novavax, Peloton, Upstart Slump Premarket; Vroom, Biohaven Soar [May-10-22 03:51AM]
-
Former heads of state urge U.S. to commit $5 billion to global COVID battle, urge Biden to take more forceful role at Thursday summit [May-10-22 10:22AM]
-
Why Novavax Stock Is Sinking Today [May-10-22 10:39AM]
-
Novavax Stock Falls as Profit and Sales Badly Trail Estimates [May-10-22 10:59AM]
-
Former global leaders urge U.S. to commit $5 billion to global COVID battle, urge Biden to take more forceful role at Thursday summit [May-10-22 10:22AM]
-
Is Novavax Stock A Sell After Its First Covid Vaccine Quarter Misses Projections? [May-10-22 12:46PM]
|
28-02-2022 |
AH |
4:00 PM ET (Feb 28) |
NVAX |
Novavax, Inc. |
6,040 |
-11.18 |
-1.43 |
-2.70 |
Novavax Non-GAAP EPS of -$11.18 misses by $9.38, revenue of $222.2M misses by $109.59M [2/28/2022 4:05 PM] |
83.71 |
0.34 (0.41%) |
79.05 |
-4.32 (-5.18%) |
66.38 - 277.80 |
6,429,157 |
3,770,000 |
97,111 |
|
|
04-11-2021 |
AH |
4:05 PM ET (Nov 4) |
NVAX |
Novavax, Inc. |
12,840 |
-4.31 |
-4.04 |
-3.21 |
Novavax EPS misses by $0.58, misses on revenue [11/4/2021 4:08 PM] |
159.02 |
-20.39 (-11.36%) |
160.50 |
-18.91 (-10.54%) |
76.59 - 331.68 |
11,115,817 |
5,640,000 |
1,071,681 |
|
-
Moderna drags COVID-19 vaccine developers lower after slashing outlook [11/4/2021 9:00 AM]
-
Novavax EPS misses by $0.58, misses on revenue [11/4/2021 4:08 PM]
-
Novavax to target over 2 billion COVID-19 vaccine doses in 2022 [11/4/2021 4:21 PM]
-
Moderna, Novavax down big after earnings disappointments, Pfizer COVID-19 pill data [11/5/2021 10:16 AM]
-
COVID-19 vaccine has an incredibly positive benefit to risk ratio: Doctor [Nov-03-21 05:35PM]
-
3 COVID Stocks for the Booster Market [Nov-03-21 04:00PM]
-
HAGENS BERMAN, NATIONAL TRIAL ATTOREYS, Encourages Novavax (NVAX) Investors with Significant Losses to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations [Nov-03-21 03:30PM]
-
Is Novavax Stock A Buy After Submitting Its Covid Vaccine To Multiple Countries? [Nov-03-21 03:02PM]
-
President Of Novavax Sold $100K In Stock [Nov-03-21 11:30AM]
-
Drug, Biotech Stock Q3 Earnings on Nov 4: MRNA, REGN & More [Nov-03-21 11:04AM]
-
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand [Nov-03-21 09:30AM]
-
The 1 Thing I'll be Looking for in Novavax's Earnings Report [Nov-03-21 06:30AM]
-
5 Biotech Stocks With 105% to 386% Upside, According to Wall Street [Nov-03-21 05:51AM]
-
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages Investors with Losses of $500,000 to Contact the Firm [Nov-03-21 01:10AM]
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX [Nov-04-21 03:16AM]
-
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages Investors with Losses of $500,000 to Contact the Firm [Nov-04-21 09:40AM]
-
Why Novavax Stock Is Sliding Today [Nov-04-21 11:57AM]
-
Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights [Nov-04-21 04:02PM]
-
Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization [Nov-04-21 04:01PM]
-
Novavax completes filing process for COVID-19 vaccine's WHO emergency listing [Nov-04-21 04:12PM]
-
Novavax completes process for WHO emergency use approval of COVID-19 vaccine [Nov-04-21 04:12PM]
-
UPDATE 1-Novavax completes process for WHO emergency use approval of COVID-19 vaccine [Nov-04-21 04:35PM]
-
UPDATE 2-Novavax completes process for WHO emergency use approval of COVID-19 vaccine [Nov-04-21 04:35PM]
-
Novavax (NVAX) Reports Q3 Loss, Misses Revenue Estimates [Nov-04-21 06:25PM]
-
Why Novavax Shares Are Rising During Thursday's After-Hours Session [Nov-04-21 05:44PM]
-
Novavax Inc (NVAX) Q3 2021 Earnings Call Transcript [Nov-04-21 10:32PM]
-
It's Time to Buy Novavax After the Biotech's Q3 Update [Nov-05-21 05:53AM]
-
Why Pfizer Gained $32 Billion in Market Capitalization Today [Nov-05-21 08:52AM]
-
Here's Why Shares of Moderna, Novavax, and Ocugen Have All Been Extremely Volatile This Week [Nov-05-21 09:42AM]
-
Novavaxs stock continues to drop following earnings. But its not all bad news. [Nov-05-21 11:41AM]
-
Is It Time to Buy the Nasdaq's 4 Worst-Performing October Stocks? [Nov-05-21 01:06PM]
-
Novavax's (NVAX) Q3 Loss Widens, Revenues Lag Estimates [Nov-05-21 01:02PM]
-
Is Novavax Stock A Sell As Rivalries Deepen Against Its Covid Vaccine? [Nov-05-21 03:45PM]
|
05-08-2021 |
AH |
4:00 PM ET (Aug 5) |
NVAX |
Novavax, Inc. |
13,970 |
-4.75 |
-3.76 |
-0.30 |
Novavax EPS misses by $1.50, misses on revenue; shares plummet [8/5/2021 4:07 PM] |
189.36 |
-46.84 (-19.83%) |
200.00 |
-36.20 (-15.33%) |
76.59 - 331.68 |
14,124,369 |
4,850,000 |
763,143 |
|
-
Novavax tumbles on delayed FDA submission for COVID-19 vaccine; U.S. to pause funding for production [8/6/2021 5:25 AM]
-
Novavax defended at Cantor citing prospects for COVID-19 shot outside U.S. [8/6/2021 4:49 PM]
-
Here's Why Novavax Stock Soared Today [Aug-04-21 06:05PM]
-
GM stock drops, EU seals deal with Novavax, Boeing 737 MAX heads to China, Robinhoods rally may fizzle [Aug-04-21 02:46PM]
-
Music events like Lollapalooza are not safe right now: Doctor [Aug-04-21 02:12PM]
-
These 2 Soaring Biotech Stocks Are Making the Nasdaq Stronger [Aug-04-21 01:10PM]
-
Novavax Is Set to Provide Europe With Up to 200 Million Covid-19 Vaccines. The Stock Is Soaring. [Aug-04-21 11:33AM]
-
Europe signs agreement for up to 200 million doses of Novavax's experimental COVID-19 shot [Aug-04-21 09:44AM]
-
UPDATE 2-EU seals deal with Novavax for up to 200 million COVID-19 vaccines [Aug-04-21 09:29AM]
-
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine [Aug-04-21 09:10AM]
-
EU seals deal with Novavax for up to 200 million COVID-19 vaccines [Aug-04-21 09:09AM]
-
5 Top Stock Gainers for Wednesday: Novavax, BeyondSpring, New York Times [Aug-04-21 08:08AM]
-
Novavax Stock Jumps on EU COVID-19 Vaccine Deal [Aug-04-21 07:30AM]
-
Novavax shares pop after clinching COVID vaccine supply deal with European Union [Aug-05-21 08:31AM]
-
Why Novavax Is Rallying Again Today [Aug-05-21 01:04PM]
-
Doctor on booster shots: People shouldnt be so anxious to get another shot [Aug-05-21 01:47PM]
-
Coronavirus vaccine: More people vaccinated is more important than boosters, doctor says [Aug-05-21 01:47PM]
-
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination [Aug-05-21 04:04PM]
-
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine [Aug-05-21 04:03PM]
-
Novavax again delays seeking U.S. approval for COVID-19 vaccine [Aug-05-21 04:05PM]
-
Novavax data shows four-fold jump in antibody levels via booster shots [Aug-05-21 04:31PM]
-
Novavax stock drops as wider-than-expected loss overshadows vaccine booster data [Aug-05-21 05:12PM]
-
Novavax Readies Its Vaccine to Fight Covid World-Wide [Aug-05-21 05:51PM]
-
Novavax Reports Second Quarter 2021 Financial Results and Operational Highlights [Aug-05-21 04:05PM]
-
Novavax (NVAX) Reports Q2 Loss, Misses Revenue Estimates [Aug-05-21 08:35PM]
-
Jobs Report, DraftKings, Virgin Galactic, Novavax, AMC - 5 Things You Must Know [Aug-06-21 01:09AM]
-
Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week [Aug-06-21 05:58AM]
-
Stock Market Steady Ahead of July Jobs Report; Novavax, Robinhood In Focus [Aug-06-21 01:56AM]
-
Novavax Stock Slumps Amid Delays In Seeking FDA COVID Vaccine Approval [Aug-06-21 02:20AM]
-
Novavax Stock Slumps Amid Delays in Seeking FDA COVID Vaccine Approval [Aug-06-21 02:20AM]
-
Novavax stock drops after it delays emergency use submission to FDA of COVID-19 vaccine [Aug-06-21 08:02AM]
-
Novavax, FireEye, and Expedia Stocks Are Tumbling and What Else Is Happening in the Stock Market Friday [Aug-06-21 08:16AM]
-
Stock Market Higher On Jobs Report: 943,000 Additions Add to Fed Rate Pressures [Aug-06-21 04:45AM]
-
Premarket Movers Friday: Plug Power, Novavax, Switch [Aug-06-21 04:41AM]
-
Novavax Reverses Winning Spree On Yet Another Delay For Its Covid Vaccine [Aug-06-21 09:52AM]
-
10 Popular Stocks to Buy Right Now [Aug-06-21 10:12AM]
-
Novavax Tanks As It Delays Seeking Emergency Use OK For Covid Shot [Aug-06-21 06:48AM]
-
Novavax's (NVAX) Q2 Loss Widens, Revenues Miss, Shares Down [Aug-06-21 11:55AM]
-
Booster shots are an ethical question we have to look at: Doctor [Aug-06-21 02:08PM]
-
Is Novavax Stock A Buy Or Sell On Another Delay For Its Covid Vaccine? [Aug-06-21 02:26PM]
-
Novavax Readies Its Vaccine to Fight Covid Worldwide [Aug-06-21 06:43AM]
-
Novavax CEO: The headline of delaying our vaccine filing in the U.S. is not accurate [Aug-06-21 03:15PM]
-
Novavax CEO explains delay in COVID-19 vaccine EUA filing [Aug-06-21 03:31PM]
-
Why Novavax Stock Crashed Today [Aug-06-21 05:38PM]
-
Why Novavax (NVAX) Stock Fell 19% on Friday [Aug-06-21 05:08PM]
-
10 Reddit WallStreetBets Stocks That are Rising [Aug-06-21 04:17PM]
-
Why Novavax Stock Is Down By 19% Today [Aug-06-21 11:28AM]
|
10-05-2021 |
AH |
4:00 PM ET (May 10) |
NVAX |
Novavax, Inc. |
12,780 |
-3.05 |
-2.65 |
-0.58 |
Novavax EPS beats by $0.55, beats on revenue [5/10/2021 4:03 PM] |
138.11 |
-22.39 (-13.95%) |
135.10 |
-25.40 (-15.83%) |
19.62 - 331.68 |
7,602,887 |
5,230,000 |
419,397 |
|
-
Novavax under pressure amid reports of delayed FDA submission for COVID-19 shot [5/10/2021 9:05 AM]
-
Novavax reports positive preclinical data for influenza and COVID-19 vaccine combo [5/10/2021 9:29 AM]
-
Novavax EPS beats by $0.55, beats on revenue [5/10/2021 4:03 PM]
-
Novavax trades lower on delayed regulatory submission for COVID-19 vaccine [5/10/2021 4:35 PM]
-
Novavax might prioritize COVID-19 vaccine deliveries to low-income countries: CEO [5/11/2021 12:39 PM]
-
Vaccine Stocks Take Wild Ride Amid Political Clash, Earnings [May-07-21 04:30PM]
-
We are not out of the woods with this pandemic: Doctor [May-07-21 02:04PM]
-
Pfizer begins process of seeking full U.S. vaccine approval: RPT [May-07-21 01:54PM]
-
UPDATE 1-Novavax expects COVID-19 vaccine supply in Japan well into 2022 [May-07-21 09:17AM]
-
Does Ocugen Have a Real Shot at the U.S. COVID Vaccine Market? [May-07-21 06:15AM]
-
Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate [May-10-21 09:12AM]
-
Novavaxs Covid-19 Vaccine Could Still Be Months Off [May-10-21 11:10AM]
-
Novavax Slumps on Dismay Over Vague Timelines for Covid Vaccine [May-10-21 11:40AM]
-
Novavax Drops on Reports of Vaccine Delay [May-10-21 07:31AM]
-
Novavax Slips on Reported Delay to Seek FDA Vaccine Clearance [May-10-21 08:35AM]
-
Novavax Slumps as Muddy Covid-19 Vaccine Timelines Spook Holders [May-10-21 11:40AM]
-
COVID-19 is not at the point yet where we can have mass gatherings: Doctor [May-10-21 01:53PM]
-
Novavax Reports First Quarter 2021 Financial Results and Operational Highlights [May-10-21 04:02PM]
-
Novavax Slumps on Dismay Over Vague Timelines for Covid Shot [May-10-21 04:01PM]
-
Novavax Q1 revenue beats estimates [May-10-21 04:30PM]
-
Novavax again delays COVID-19 vaccine production timeline, shares fall [May-10-21 04:17PM]
-
Why Shares Of Novavax Are Down By 8% Today? [May-10-21 11:43AM]
-
Novavax delays COVID-19 vaccine production timeline, sees filing for authorization in 3rd qtr [May-10-21 04:17PM]
-
WHO classifies triple-mutant Covid variant from India as global health risk [May-10-21 05:32PM]
-
Novavax Drops on Delay in Vaccine Clearance Request [May-10-21 02:21PM]
-
Why Novavax Tanked Monday [May-10-21 06:26PM]
-
Novavax delays timelines for COVID-19 vaccine regulatory filings, production [May-10-21 04:17PM]
-
Novavax (NVAX) Reports Q1 Loss, Tops Revenue Estimates [May-10-21 05:55PM]
-
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know [May-10-21 05:50PM]
-
Novavax Plunges Amid Dismay Over Timeline for Covid-19 Shot [May-10-21 07:37PM]
-
Novavax Swings to a 1Q Loss; Shares Plunge 9% [May-11-21 05:13AM]
-
Here's the Only Thing in Novavax's Q1 Update That Investors Cared About [May-11-21 05:52AM]
-
Novavax Shares Tumble as Vaccine Delays Mount [May-11-21 08:15AM]
-
Devon Energy, Bilibili, Novavax, Roblox and Wynn Resorts highlighted as Zacks Bull and Bear of the Day [May-11-21 07:31AM]
-
Premarket Movers Tuesday - Tesla, Palantir, Novavax, Virgin Galactic [May-11-21 04:11AM]
-
Global cases and deaths from COVID-19 are plateauing but Indias crisis continues to deepen [May-11-21 10:30AM]
-
Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints [May-11-21 10:40AM]
-
Is Novavax Stock A Sell After Announcing Another Covid Vaccine Delay? [May-11-21 11:40AM]
-
Novavax's (NVAX) Q1 Loss Widens, Revenues Beat, Shares Down [May-11-21 12:22PM]
-
Novavax Down Second Straight Day On Concerns About Delays [May-11-21 09:10AM]
-
COVID-19 booster shot is likely and its okay: Doctor [May-11-21 02:09PM]
-
Why Novavax Stock Sank Again on Tuesday [May-11-21 05:51PM]
|
01-03-2021 |
AH |
4:05 PM ET (Mar 1) |
NVAX |
Novavax, Inc. |
14,900 |
-2.70 |
-1.53 |
-1.13 |
Novavax EPS misses by $0.46, beats on revenue [3/1/2021 4:06 PM] |
206.81 |
-33.48 (-13.93%) |
226.95 |
-13.34 (-5.55%) |
6.77 - 331.68 |
6,122,307 |
2,809,915 |
39,544 |
|
|
09-11-2020 |
AH |
4:00 PM ET (Nov 9) |
NVAX |
Novavax, Inc. |
5,710 |
-3.21 |
2.36 |
-1.03 |
Novavax EPS misses by $4.94, misses on revenue [11/9/2020 4:10 PM] |
78.58 |
-11.73 (-12.99%) |
85.32 |
-4.99 (-5.53%) |
3.54 - 189.40 |
6,585,151 |
2,880,346 |
104,856 |
|
|
10-08-2020 |
AH |
4:05 PM ET (Aug 10) |
NVAX |
Novavax, Inc. |
9,830 |
-0.30 |
-0.60 |
-1.69 |
Novavax EPS beats by $0.23, beats on revenue [8/10/2020 4:04 PM] |
164.88 |
-13.63 (-7.64%) |
169.99 |
-8.52 (-4.77%) |
3.54 - 189.40 |
9,262,062 |
7,937,483 |
219,943 |
|
|